Tech Leadership Returns: Mega-Caps Anchor Market Rally Once Again

September 24, 2024

The tailwinds providing resilience to the market and the Global Growth Portfolio

As the market rally continues, which factors are offering momentum, while also serving the resilience of the Global Growth Portfolio?


Since the market sell-off in April, global equities have effectively been on a non-stop run.

While the odd risk to the market rally has presented itself, little has stood in the way of a bull run that is increasingly mirroring the sort of trading action we saw in the wake of the COVID flash crash back in 2020.

In fact, one could realistically build the case that there are a number of tailwinds that have added weight to the current market outlook and overall positive sentiment.

Extending this further, it’s also not hard to see why our Global Growth Portfolio is leveraged to a number of encouraging developments.

Federal Reserve conviction

Although the Federal Reserve is tipped to cut rates over the coming months - in itself, a boon for equities - the central bank has oftentimes signalled confidence in the world’s largest economy.

In turn, this has allowed US equities to hold gains, and it speaks to the natural resilience of the US economy, which of course underpins the stock market.

As recently as the end of July, the Fed touted the underlying strength of the US economy, citing “solid” labour market conditions, while also avoiding negative language associated with a moderation in overall growth.

Even if conditions may have softened since, the Fed, and in particular, Chair Jerome Powell, are on record as describing the US economy as being in a “solid position”.

With rate cuts to follow, this is likely to shore up the economy and provide a further boost to the economic growth outlook.

Tech leadership

It has long been recognised that US markets are heavily influenced by a small cohort of stocks, most of which come from the tech sector.

While the sector’s leadership subsided a few months back, this trend has reversed course, with tech stalwarts rising to the fore once again to underpin the market rally.

Overall, mega-tech companies like Apple, Microsoft, and Nvidia have maintained their share price momentum post-earnings, offering a vital foundation for investors to grow in confidence.

In fact, this has also been a fundamental driver for our Global Growth Portfolio. The success of these names also represents a strong validation for our core holdings in said Portfolio.

Global economic conditions

By and large, the global economic story is holding up well. Although concerns remain around China, the world’s second largest economy has still delivered solid growth.

The slowdown being witnessed there might seem counterintuitive to equities strength, however, this ignores the reality that such conditions have only bolstered the case for fresh economic stimulus.

Meanwhile, positive economic data out of Europe and Japan is supporting global growth sentiment. These economies have shown signs of improvement, and it is by no means a coincidence that this has also coincided with a first-half showing where equities from these regions outperformed the US market in USD-denominated terms.

Our Global Growth Portfolio retains international exposure thanks to the diversified nature of several of our holdings, with a number of businesses that conduct operations across the world.

Earnings season beats the odds

The most recent earnings season showcased resilient corporate performance despite uncertainty tied to trade tariffs and moderating economic growth.

Across the period, companies largely topped expectations. In fact, approximately 82% of S&P 500 companies exceeded EPS estimates, which is well ahead of the 10-year average for said metric, which stands at 75%.

Even more impressive, around 81% of companies beat revenue estimates, far better than the 10-year average of 64%. It was also the highest ‘beat rate’ in three years.

The resilience of earnings season spread far and wide, initially underpinned by the banks, then given extra momentum courtesy of the tech sector, before being ably supported by results from consumer and healthcare names.

With the above in mind, the diversity of our Portfolio lends itself well to such a backdrop, with sector results offering another layer of resilience to the underlying strength of our Portfolio - notwithstanding adverse foreign exchange movements.

Nevertheless, despite a swathe of favourable tailwinds supporting both the market and the Global Growth Portfolio, we have chosen to make some adjustments to support targeting sustainable growth.

Portfolio Additions

Amazon (AMZN) – Increased to 6%

We’ve lifted our allocation to Amazon to reflect the company’s ongoing strength across multiple growth engines.

For starters, its AWS division remains the global leader in cloud computing, which is a market where we still see considerable growth over the coming decades.

At the same time, Amazon’s logistics and e-commerce infrastructure retain exceptional pricing power, which is beneficial to growing earnings.

As the tech giant pushes deeper into AI, we see significant opportunities for the company to monetise its capabilities and expand revenue streams to drive growth.

McDonald’s (MCD) – Increased to 4%

Having shown impressive resilience through economic cycles, we’ve made the decision to boost our holdings in McDonald’s.

One of the key things we like about McDonald’s, especially in the face of an uncertain economic outlook, is the company’s defensive cash flows based on its pricing power.

But unlike traditional ‘defensive’ names, McDonald’s has an impressive record when it comes to innovation, whether that be related to digital ordering, delivery platforms, or menu localisation. The company’s global presence and exposure to different economic cycles supports its status as an anchor consumer holding.

Northrop Grumman (NOC) – Increased to 2.5%

While NOC might be considered a defensive play, we actually like the company for its long-term growth outlook. This is a central factor in our decision to expand our position here.

Keeping in mind the company’s operational capabilities, which include leadership across space systems, missile defence, and classified technology projects, we appreciate that NOC is leveraged to higher-growth defence segments.

UnitedHealth Group (UNH) – Increased to 3%

It is our belief that the various sell-offs in UNH this year have proved an opportune moment for investors to acquire a high quality business at an attractive price.

As healthcare remains a long-term growth theme, we see UNH as being uniquely positioned amid unfolding demographic trends. It is the US’s largest integrated healthcare provider, and its diversified model - combining insurance, data analytics, and care delivery - offers both defensive stability and attractive growth.

Waste Management (WM) – New 2% position

A new addition to our Portfolio, Waste Management meets several of our criteria for investment.

Above all else, we consider it an attractive complement to our higher-growth technology positions. Key attributes of the company include inflation-linked pricing, recurring cash flows, and rising demand for sustainable waste solutions.

It is our view that WM could add further resilience to the Portfolio.

Portfolio Removals

Nvidia (NVDA) – Reduced to 7%

While it may come as a shock to some of our clients that we have chosen to downsize our position in Nvidia - the AI flagbearer that has almost single-handedly given life to the multi-year bull run - our decision reflects risk management.

Ultimately, we continue to see immense upside over the long run for Nvidia as AI infrastructure becomes more important, but we are conscious about risk exposure after such rapid appreciation. Still, Nvidia remains a core Portfolio holding, reflecting its dominance in AI chips and expanding software ecosystem.

Intuitive Surgical (ISRG) – Reduced to 3.5%

Since we first took a position in ISRG, the stock has delivered significant returns. At first it was the smallest company we owned by market cap, but it has since grown into its value as the adoption of robotic surgery has accelerated globally.

Despite the growth story, we’re trimming our position in ISRG slightly to lock in gains and manage position sizing. We retain strong conviction in ISRG’s long-term growth trajectory as robotic-assisted procedures are still only a fraction of the global total, which we believe gives ISRG decades of runway.

Lockheed Martin (LMT) – Sold

We’ve exited Lockheed Martin to redeploy funds into other opportunities where we see higher forward growth potential. While LMT remains a strong contractor, its focus is more aligned with mature defence platforms.

Instead, we favour Raytheon (RTX) and Northrop Grumman (NOC), which have greater exposure to advanced defence technologies, missile systems, and space. We believe these firms are better leveraged to the future direction of defence spending.

SGOV & SHV – Sold

We’ve exited our short-term US treasury ETF positions, SGOV and SHV. With yields now stabilising, the opportunity cost of holding these instruments is rising, and we prefer to deploy capital into equities with growth and compounding potential.

BUSINESS
August 10, 2025
Tagged:
Markets

Tech Leadership Returns: Mega-Caps Anchor Market Rally Once Again

Accounting Solutions Tailored to Your Needs, Your Go-To Source for Accounting Knowledge and Tools.

The tailwinds providing resilience to the market and the Global Growth Portfolio

As the market rally continues, which factors are offering momentum, while also serving the resilience of the Global Growth Portfolio?


Since the market sell-off in April, global equities have effectively been on a non-stop run.

While the odd risk to the market rally has presented itself, little has stood in the way of a bull run that is increasingly mirroring the sort of trading action we saw in the wake of the COVID flash crash back in 2020.

In fact, one could realistically build the case that there are a number of tailwinds that have added weight to the current market outlook and overall positive sentiment.

Extending this further, it’s also not hard to see why our Global Growth Portfolio is leveraged to a number of encouraging developments.

Federal Reserve conviction

Although the Federal Reserve is tipped to cut rates over the coming months - in itself, a boon for equities - the central bank has oftentimes signalled confidence in the world’s largest economy.

In turn, this has allowed US equities to hold gains, and it speaks to the natural resilience of the US economy, which of course underpins the stock market.

As recently as the end of July, the Fed touted the underlying strength of the US economy, citing “solid” labour market conditions, while also avoiding negative language associated with a moderation in overall growth.

Even if conditions may have softened since, the Fed, and in particular, Chair Jerome Powell, are on record as describing the US economy as being in a “solid position”.

With rate cuts to follow, this is likely to shore up the economy and provide a further boost to the economic growth outlook.

Tech leadership

It has long been recognised that US markets are heavily influenced by a small cohort of stocks, most of which come from the tech sector.

While the sector’s leadership subsided a few months back, this trend has reversed course, with tech stalwarts rising to the fore once again to underpin the market rally.

Overall, mega-tech companies like Apple, Microsoft, and Nvidia have maintained their share price momentum post-earnings, offering a vital foundation for investors to grow in confidence.

In fact, this has also been a fundamental driver for our Global Growth Portfolio. The success of these names also represents a strong validation for our core holdings in said Portfolio.

Global economic conditions

By and large, the global economic story is holding up well. Although concerns remain around China, the world’s second largest economy has still delivered solid growth.

The slowdown being witnessed there might seem counterintuitive to equities strength, however, this ignores the reality that such conditions have only bolstered the case for fresh economic stimulus.

Meanwhile, positive economic data out of Europe and Japan is supporting global growth sentiment. These economies have shown signs of improvement, and it is by no means a coincidence that this has also coincided with a first-half showing where equities from these regions outperformed the US market in USD-denominated terms.

Our Global Growth Portfolio retains international exposure thanks to the diversified nature of several of our holdings, with a number of businesses that conduct operations across the world.

Earnings season beats the odds

The most recent earnings season showcased resilient corporate performance despite uncertainty tied to trade tariffs and moderating economic growth.

Across the period, companies largely topped expectations. In fact, approximately 82% of S&P 500 companies exceeded EPS estimates, which is well ahead of the 10-year average for said metric, which stands at 75%.

Even more impressive, around 81% of companies beat revenue estimates, far better than the 10-year average of 64%. It was also the highest ‘beat rate’ in three years.

The resilience of earnings season spread far and wide, initially underpinned by the banks, then given extra momentum courtesy of the tech sector, before being ably supported by results from consumer and healthcare names.

With the above in mind, the diversity of our Portfolio lends itself well to such a backdrop, with sector results offering another layer of resilience to the underlying strength of our Portfolio - notwithstanding adverse foreign exchange movements.

Nevertheless, despite a swathe of favourable tailwinds supporting both the market and the Global Growth Portfolio, we have chosen to make some adjustments to support targeting sustainable growth.

Portfolio Additions

Amazon (AMZN) – Increased to 6%

We’ve lifted our allocation to Amazon to reflect the company’s ongoing strength across multiple growth engines.

For starters, its AWS division remains the global leader in cloud computing, which is a market where we still see considerable growth over the coming decades.

At the same time, Amazon’s logistics and e-commerce infrastructure retain exceptional pricing power, which is beneficial to growing earnings.

As the tech giant pushes deeper into AI, we see significant opportunities for the company to monetise its capabilities and expand revenue streams to drive growth.

McDonald’s (MCD) – Increased to 4%

Having shown impressive resilience through economic cycles, we’ve made the decision to boost our holdings in McDonald’s.

One of the key things we like about McDonald’s, especially in the face of an uncertain economic outlook, is the company’s defensive cash flows based on its pricing power.

But unlike traditional ‘defensive’ names, McDonald’s has an impressive record when it comes to innovation, whether that be related to digital ordering, delivery platforms, or menu localisation. The company’s global presence and exposure to different economic cycles supports its status as an anchor consumer holding.

Northrop Grumman (NOC) – Increased to 2.5%

While NOC might be considered a defensive play, we actually like the company for its long-term growth outlook. This is a central factor in our decision to expand our position here.

Keeping in mind the company’s operational capabilities, which include leadership across space systems, missile defence, and classified technology projects, we appreciate that NOC is leveraged to higher-growth defence segments.

UnitedHealth Group (UNH) – Increased to 3%

It is our belief that the various sell-offs in UNH this year have proved an opportune moment for investors to acquire a high quality business at an attractive price.

As healthcare remains a long-term growth theme, we see UNH as being uniquely positioned amid unfolding demographic trends. It is the US’s largest integrated healthcare provider, and its diversified model - combining insurance, data analytics, and care delivery - offers both defensive stability and attractive growth.

Waste Management (WM) – New 2% position

A new addition to our Portfolio, Waste Management meets several of our criteria for investment.

Above all else, we consider it an attractive complement to our higher-growth technology positions. Key attributes of the company include inflation-linked pricing, recurring cash flows, and rising demand for sustainable waste solutions.

It is our view that WM could add further resilience to the Portfolio.

Portfolio Removals

Nvidia (NVDA) – Reduced to 7%

While it may come as a shock to some of our clients that we have chosen to downsize our position in Nvidia - the AI flagbearer that has almost single-handedly given life to the multi-year bull run - our decision reflects risk management.

Ultimately, we continue to see immense upside over the long run for Nvidia as AI infrastructure becomes more important, but we are conscious about risk exposure after such rapid appreciation. Still, Nvidia remains a core Portfolio holding, reflecting its dominance in AI chips and expanding software ecosystem.

Intuitive Surgical (ISRG) – Reduced to 3.5%

Since we first took a position in ISRG, the stock has delivered significant returns. At first it was the smallest company we owned by market cap, but it has since grown into its value as the adoption of robotic surgery has accelerated globally.

Despite the growth story, we’re trimming our position in ISRG slightly to lock in gains and manage position sizing. We retain strong conviction in ISRG’s long-term growth trajectory as robotic-assisted procedures are still only a fraction of the global total, which we believe gives ISRG decades of runway.

Lockheed Martin (LMT) – Sold

We’ve exited Lockheed Martin to redeploy funds into other opportunities where we see higher forward growth potential. While LMT remains a strong contractor, its focus is more aligned with mature defence platforms.

Instead, we favour Raytheon (RTX) and Northrop Grumman (NOC), which have greater exposure to advanced defence technologies, missile systems, and space. We believe these firms are better leveraged to the future direction of defence spending.

SGOV & SHV – Sold

We’ve exited our short-term US treasury ETF positions, SGOV and SHV. With yields now stabilising, the opportunity cost of holding these instruments is rising, and we prefer to deploy capital into equities with growth and compounding potential.

International

INTERNATIONAL GROWTH PORTFOLIO

Through August the Global Growth Portfolio recorded a modest decline in Net Asset Value (NAV) to the tune of 0.8%, ultimately weighed down by adverse foreign exchange movements.

Undoing some of the appreciation in the greenback a month prior, the USD/AUD pair declined from 1.5564 to 1.5289, which in its own right resulted in a drag of about 2.0% on the Portfolio.

With that said, underlying returns for the Portfolio were positive through the month, with a good breadth of names contributing to said result.

Despite this, the Portfolio fell short of matching the returns of the major indices, with the S&P 500 gaining 1.9% over the month, the Nasdaq Composite up 1.6%, and the Dow Jones advancing 3.2%.

On the positive side of the ledger for the Portfolio, Apple (AAPL), Berkshire Hathaway (BRK.B), Alphabet (GOOGL), and UnitedHealth Group (UNH) were among the biggest contributors to returns.

Of that cohort, Apple excelled, delivering its best monthly return in over a year when it surged 11.8%. That was in response to a commitment of US$100 billion in investments towards US domestic manufacturing, which in turn eased concerns about the impact of any tariffs on the tech giant.

We expect this development to reduce the overhang that has surrounded the stock since news first broke about global trade tariffs.

Meanwhile, shares in Alphabet touched a new all time high, up 11.0% for the month. The stock has continued to benefit from momentum surrounding its AI infrastructure and generative AI solutions, and since the end of the month, the stock also received a favourable ruling with regards to an anti-trust case before the courts.

As far as Berkshire Hathaway and UnitedHealth Group, their fortunes were tied last month. After some months of weakness, buyers stepped in to support BRK.B, which as it so happens, revealed that it was a buyer of shares in UNH through the second quarter of the year.

As far as the latter, UNH benefitted from a strong earnings announcement where it reinstated its full year outlook, and management also laid out a path to return to earnings growth in 2026.

However, there were also a number of names that struggled through August, including CrowdStrike (CRWD), Microsoft (MSFT), Nvidia (NVDA), and Taiwan Semiconductor Manufacturing (TSM).

While chip producers like Nvidia and Taiwan Semiconductor have enjoyed a prolific rise thanks to unprecedented interest in AI hardware, their share prices cooled last month as Nvidia reported results that fell short in its all-important data centre segment, and with uncertainty surrounding its chip exports to China.

As with Microsoft, which shed 5%, we believe such pull-backs are likely to be minor blips when assessed across the long-term, with the investment theses for these names still remaining largely intact.

By the end of August, unrealised Portfolio gains represented 45.1% of NAV.

Portfolios Review: August 2025

Interest rate speculation continued to dominate the narrative in the United States, with investors growing increasingly confident about a rate cut at the Federal Reserve’s September meeting.

While August shed more light around internal division on rates at the Fed, and even pressure from the government to enact rate cuts, investors largely maintained strong conviction towards US equities.

Some defensive names and industrials returned to the spotlight, but mega-tech also held sway over proceedings thanks to a renewed focus on Apple.

Locally, Australian equities delivered strong returns, with the benchmark S&P/ASX 200 index advancing 2.6% for the month.

On the back of said performance, the index delivered its best August result since the Global Financial Crisis back in 2009.

It was also the fifth consecutive monthly increase for the ASX, underpinned by Materials, Consumer Discretionary, and Financials shares.

However, the month didn’t pass without a hitch, as the Health Care sector found itself sold off sharply, and Energy shares also weighed on overall market returns.

But the market did breach the 9,000-point threshold for the first time ever, even closing above said level before easing slightly in the opening days of September.

Australian shares deliver strong returns despite volatile earnings season

Each of our Portfolios benefitted from a solid showing by the local share market, whereby we retain exposure to the ASX courtesy of holdings like the Betashares Australia 200 ETF (A200) and the Betashares Australian Quality ETF (AQLT).

Even though the ASX delivered a strong headline return over the course of the month, there was exceptional volatility among popular names through August.

According to JPMorgan, just 21% of ASX 200 companies topped earnings expectations, 55% met expectations, and a notable 24% of said cohort missed earnings forecasts.

Overall, it was a fairly dire reporting period for the local market, and we even saw various blue-chip names fall victim to brutal sell-offs.

For example, biotech giant CSL (CSL) slumped 21.4% over the course of the month, while building materials supplier James Hardie (JHX) tumbled 24.6% during the same period.

These were among the highest profile names that underwhelmed investors, but it also represented a common theme through reporting season that centred on a general downwards revision to earnings.

Nevertheless, there were some exceptions, with companies like Brambles (BXB) and even Westpac (WBC) proving that size should serve as no barrier when it comes to share price rallies.

Analysis conducted by JPMorgan found that just 18% of companies saw their earnings forecasts upgraded by analysts, whereas 36% saw downgrades.

Elsewhere, the ASX was also supported by resources stocks, including the likes of Pilbara Minerals (PLS), which delivered a monthly gain in excess of 50% on the back of a rebound in lithium prices.

While our exposure to Australian equities was weighed down somewhat by BKI Investment (BKI), which shed nearly 5% for the month, this also reflected the stock trading ex-dividend.

Even so, with our ASX holdings more closely aligned with large-cap stocks, the broader trend of a robust performance from the ASX 200 helped underpin Portfolio gains and offset individual declines among select ASX names.

This also offers context as to why the performance differentials between our various Portfolios were more narrow than in other months despite a bullish backdrop, as the Conservative and Balanced Portfolios feature a greater weight towards local equities compared with our growth-oriented Portfolios.

Hybrid income shores up defensive returns

Another favourable tailwind for our Portfolios, albeit with more weight supporting the Conservative Portfolio, was the performance of our hybrids.

Although bank hybrids will eventually be phased out, and spreads have gradually tightened, this asset class currently offers what we deem to be compelling income opportunities.

At the time of writing, running yields on major bank-issued hybrids remain particularly attractive, typically exceeding 6%, and even stretching towards 8.5%.

The low volatility associated with these positions is aligned with our preference for price stability across defensive assets, and there is buoyant demand supporting this corner of the market.

Infrastructure continues to support asset class diversification

Having been a resounding factor in the outperformance of our Portfolios against comparable superannuation investment options offered by some of Australia’s most popular funds, infrastructure continues to deliver a robust contribution to returns.

The inclusion of the VanEck FTSE Global Infrastructure Hedged ETF (IFRA) and the Vanguard Global Infrastructure Index ETF (VBLD) were favourable for our overall returns last month, and across each of our Portfolios.

In the case of the IFRA ETF, currency hedging helped secure the underlying gains associated with the assets held by the fund. On the other hand, VBLD was exposed to a weaker US dollar, and this has since continued through the early part of September, so we expect there may be some downwards pressure in the next result.

Infrastructure has proven itself an invaluable asset class over the last 18 months, and it remains a central component to our Portfolios, but one where we remain conscious as to the risks of forex movements.

International equities record mixed results despite rally extending through August

One of the key reasons why our Portfolios, especially our growth-oriented Portfolios fell short of market returns amid a bullish backdrop last month was due to the returns yielded by our global equities.

On this front, currency exposure played a significant role as a headwind.

Funds like the iShares S&P 500 ETF (IVV) and the VanEck MSCI International Quality ETF (QUAL) offered little to no contribution towards overall performance in August, while the Betashares Nasdaq 100 ETF (NDQ) dragged on overall returns.

However, it must be said that these holdings have delivered strong results over recent times, so while minor discrepancies like this may lead to underperformance over a short horizon, we are looking at the bigger picture, where in our view, the growth outlook still offers an abundance of opportunities.

What’s more, we do hold some hedged positions like the Betashares Nasdaq 100 Currency Hedged ETF (HNDQ) and the VanEck MSCI International Quality (Hedged) ETF (QHAL), and while overall performance was muted through August, these sorts of holdings would normally be expected to provide a cushion for this asset class, even in the face of currency headwinds.

George Wong
Senior Investment Advisor
Follow us on:

Join our newsletter for tips & insights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Receive the free Growthfront monthly newsletter and updates
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Disclaimer:
Growthfront Pty Ltd is a Corporate Authorised Representative (No. 1302922) of Geosmith Partners AFSL 700062 ABN 86 684 092 135. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs except in circumstances where you have provided your personal financial details via our online application process and received a Statement of Advice from us. Before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us